Therapeutic combination

A method for treating a mammal suffering from angina comprising administering to said mammal

• (a) an amount of a first therapeutic agent, said first agent being amlodipine or a pharmaceutically acceptable acid addition salt thereof;
• and
• (b) an amount of a second therapeutic agent, said second agent being atorvastatin or a pharmaceutically acceptable salt thereof;
• wherein said first agent and second agent are administered together in a single pharmaceutical composition containing a pharmaceutically acceptable carrier or diluent.

A method of treating a human diagnosed as suffering from angina, and who would benefit from the administration of prescribed therapeutic agents, the method comprising administering to said human

• (a) an amount of a first therapeutic agent, said first agent being amlodipine or a pharmaceutically acceptable acid addition salt thereof;
• and
• (b) an amount of a second therapeutic agent, said second agent being atorvastatin or a pharmaceutically acceptable salt thereof;
• wherein said first agent and second agent are administered together in a single pharmaceutical composition containing a pharmaceutically acceptable carrier or diluent.

A method for treating angina in a human who has been examined for angina by a medical practitioner and diagnosed in need of therapy for said angina treatment by the joint administration of a first therapeutic agent and a second therapeutic agent, which comprises administering to said human

• (a) an amount of said first therapeutic agent, said first agent being amlodipine or a pharmaceutically acceptable acid addition salt thereof;
• and
• (b) an amount of said second therapeutic agent, said second agent being atorvastatin or a pharmaceutically acceptable salt thereof;
• wherein said first agent and second agent are administered together in a single pharmaceutical composition containing a pharmaceutically acceptable carrier or diluent.